Small caps round-up: Expansys, Scancell, Inspired Energy...

Share

• Copy link
• Facebook
• X
• Linkedin
• Whatsapp
• Pinterest

Share this article

Join the conversation

Follow us

Add us as a preferred source on Google

Newsletter

Get the MoneyWeek Newsletter

Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.

Contact me with news and offers from other Future brands Receive email from us on behalf of our trusted partners or sponsors

---

By submitting your information you agree to the Terms & Conditions and Privacy Policy and are aged 16 or over.

You are now subscribed

Your newsletter sign-up was successful

---

Want to add more newsletters?

Twice daily

MoneyWeek

Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.

Signup +

Four times a week

Look After My Bills

Sign up to our free money-saving newsletter, filled with the latest news and expert advice to help you find the best tips and deals for managing your bills. Start saving today!

Signup +

---

An account already exists for this email address, please log in.

Subscribe to our newsletter

Expansys, the eCommerce company, has struck lucky in Istanbul. Its subsidiary PJ Media has won a contract to supply the official online store for Vodafone Turkey. By 11:06 eXpansys had gained 8.6%.

Scancell Holdings, the developer of therapeutic cancer vaccines, has announced it has recruited enough patients to start a Phase I clinical trial of SCIB1, its DNA vaccine being developed for the treatment of melanoma. By 11:12 the stock had risen 4.4%.

Inspired Energy has completed its acquisition of Direct Energy Purchasing. The initial consideration is for £2m (in cash and shares), plus two deferred payments of up to £1m each based primarily upon the financial performance of DEP. By 11:29 the stock had risen 6.2%.

MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

Angel Biotechnology, the biopharmaceutical contract manufacturer, has agreed a contract with US outfit TransGenRx for the development and scale up of a recombinant interferon product. The shares were up 1.27% by 11:12.

BS